about
Immune phenotype predicts risk for posttransplantation squamous cell carcinoma.Immune profiling and cancer post transplantationIncidence and prediction of nonmelanoma skin cancer post-renal transplantation: a prospective study in Queensland, Australia.Virtual Global Transplant Laboratory Standard Operating Protocol for Donor Alloantigen-specific Interferon-gamma ELISPOT AssayExperiences and perspectives of adolescents and young adults with advanced CKD.Reductions in immunosuppression after haematological or solid organ cancer diagnosis in kidney transplant recipients.Cancer-Specific and All-Cause Mortality in Kidney Transplant Recipients With and Without Previous Cancer.BK virus encoded microRNAs are present in blood of renal transplant recipients with BK viral nephropathy.Peripheral natural killer cell and allo-stimulated T-cell function in kidney transplant recipients associate with cancer risk and immunosuppression-related complications.Skin cancer surveillance in renal transplant recipients: re-evaluation of U.K. practice and comparison with Australian experience.Nutritional status of haemodialysis patients: comparison of Australian cohorts of Aboriginal and European descent.Interleukin-17A-Induced Human Mesenchymal Stem Cells Are Superior Modulators of Immunological Function.C4d-negative antibody-mediated rejection with high anti-angiotensin II type I receptor antibodies in absence of donor-specific antibodies.Angiotensin II type-1 receptor antibody (AT1Rab) associated humoral rejection and the effect of peri operative plasma exchange and candesartan.The immune phenotype may relate to cancer development in kidney transplant recipients.Patient perspectives of a young adult renal clinic: a mixed-methods evaluation.Quality of life of young adults and adolescents with chronic kidney disease.Anti-CD20 antibody treatment in refractory Class IV lupus nephritisCan the risk of skin cancer after transplantation be reduced by mTOR Inhibitors?Does rituximab help in HLA desensitization for kidney transplantation?Predictors of cancer risk in the long-term solid-organ transplant recipientAngiotensin II type 1 receptor antibody precipitating acute vascular rejection in kidney transplantation
P50
Q33748547-86CAA068-0563-4686-BBDC-EBE72E68C614Q35050810-0F686DFC-EF4A-49B2-9CC8-62D0D8702AB5Q35075913-CCCF4106-CD1F-417B-975D-4CC436D5B9E9Q37394993-4E455856-6AEF-4E7C-8751-D49ABD2D0906Q39298901-BCE1E189-CE57-4823-BDD7-F9507A148957Q40736816-DA894F71-E513-4DDB-9060-4FAEEFE75DA3Q40808374-478BC342-8415-40A8-850E-39E0B3DE4DF3Q42224669-B209098E-C86F-4782-85AB-E0EF10C4DB17Q42413517-262141FC-3D2B-4980-96E4-C5CCBD21800AQ42441839-F9B076D9-180A-4A54-AC42-7C3457ECB70EQ43887657-176BCC30-53D0-4F4E-8EDE-433D65C0AC17Q47567886-6B359533-8D84-40B1-AD98-641F7DF6249AQ47571875-C5791458-4BD1-4606-B25F-345EA938CA99Q47608906-E415C688-C4A3-4FED-A4C9-41ADB625E061Q47610143-671C8118-C5A4-4BE0-A222-FDAE974D85C2Q47751535-57B90777-5224-4792-B1C5-08AFCD9B42DDQ48218754-8973B92C-530D-400B-ABC8-3784849497BFQ79344699-331F85EF-8E7D-4DAA-9727-7841CAB7FDE1Q85891740-5111660D-0170-46FF-B510-72D5EA1207F1Q86627626-38BA8B23-EB43-4A07-9D08-04894D6AC512Q86672271-7F7DEE8F-3265-4C85-95EA-F14509253E15Q86990338-C17BDE98-279D-45F4-94EB-189F545EAA7D
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Robert P Carroll
@ast
Robert P Carroll
@en
Robert P Carroll
@es
Robert P Carroll
@nl
Robert P Carroll
@sl
type
label
Robert P Carroll
@ast
Robert P Carroll
@en
Robert P Carroll
@es
Robert P Carroll
@nl
Robert P Carroll
@sl
prefLabel
Robert P Carroll
@ast
Robert P Carroll
@en
Robert P Carroll
@es
Robert P Carroll
@nl
Robert P Carroll
@sl
P108
P106
P21
P31
P496
0000-0002-6238-026X